Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	204	184	215	205	374	238
Market Cap Growth	-15.66%	-14.53%	4.97%	-45.35%	57.45%	-12.67%
Enterprise Value	255	231	268	251	358	203
Last Close Price	8.32	7.36	8.48	7.96	14.43	9.73
PE Ratio	16.37	22.51	-	-	-	17.80
Forward PE	14.99	16.18	26.13	62.24	29.60	20.24
PS Ratio	0.81	0.75	0.85	0.99	1.92	1.35
PB Ratio	1.49	1.39	1.69	1.54	2.54	1.69
P/TBV Ratio	1.64	1.62	1.97	1.77	2.90	1.71
P/FCF Ratio	-	15.35	521.59	-	-	15.32
P/OCF Ratio	5.52	4.01	11.59	55.48	-	7.81
EV/Sales Ratio	1.02	0.95	1.07	1.22	1.84	1.15
EV/EBITDA Ratio	7.40	7.77	12.79	18.40	19.06	9.21
EV/EBIT Ratio	13.67	16.01	44.53	-	59.57	19.01
EV/FCF Ratio	-69.18	19.34	651.76	-	-	13.08
Debt / Equity Ratio	0.38	0.41	0.52	0.90	0.75	0.23
Debt / EBITDA Ratio	1.65	1.80	3.00	8.04	5.71	1.44
Debt / FCF Ratio	15.08	4.56	161.20	-	-	2.07
Asset Turnover	0.98	1.01	0.93	0.69	0.76	0.85
Inventory Turnover	4.04	4.42	4.43	4.05	5.08	5.83
Quick Ratio	0.64	0.89	0.66	1.41	1.24	1.84
Current Ratio	1.24	1.37	1.10	1.96	1.56	2.25
Return on Equity (ROE)	7.06%	6.30%	-2.71%	-6.77%	-0.99%	9.84%
Return on Assets (ROA)	3.92%	3.73%	1.39%	-0.10%	1.47%	3.20%
Return on Capital (ROIC)	5.11%	4.75%	1.69%	-0.12%	1.74%	3.98%
Return on Capital Employed (ROCE)	9.00%	8.40%	4.30%	-	3.10%	6.70%
Earnings Yield	6.11%	4.44%	-1.64%	-4.64%	-0.38%	5.62%
FCF Yield	-1.81%	6.51%	0.19%	-5.54%	-5.52%	6.53%
Dividend Yield	1.71%	1.90%	1.42%	1.26%	1.11%	1.44%
Payout Ratio	27.55%	36.02%	-	-	-	20.53%
Buyback Yield / Dilution	-	-	-	-6.76%	2.12%	-8.75%
Total Shareholder Return	1.79%	1.90%	1.42%	-5.51%	3.23%	-7.31%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.